Zhangzhou Pientzehuang Pharmaceutical., Ltd (600436.SS)
CNY 205.78
(0.67%)
CNY 205.78
(0.67%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 248.15 Million CNY | 117.89% |
| 2022 | -1.38 Billion CNY | 77.66% |
| 2021 | -6.21 Billion CNY | -39.58% |
| 2020 | -4.45 Billion CNY | -24.77% |
| 2019 | -3.56 Billion CNY | -63.08% |
| 2018 | -2.18 Billion CNY | -32.53% |
| 2017 | -1.65 Billion CNY | -56.36% |
| 2016 | -1.05 Billion CNY | 5.44% |
| 2015 | -1.11 Billion CNY | -17.12% |
| 2014 | -952.96 Million CNY | -14.54% |
| 2013 | -832.01 Million CNY | -1530.47% |
| 2012 | -51.02 Million CNY | 75.4% |
| 2011 | -207.4 Million CNY | -88.03% |
| 2010 | -110.3 Million CNY | -1302.51% |
| 2009 | -7.86 Million CNY | -212.79% |
| 2008 | 6.97 Million CNY | 104.73% |
| 2007 | -147.31 Million CNY | 41.42% |
| 2006 | -251.45 Million CNY | 5.0% |
| 2005 | -264.7 Million CNY | -9.95% |
| 2004 | -240.75 Million CNY | -22.37% |
| 2003 | -196.74 Million CNY | -269.05% |
| 2002 | -53.31 Million CNY | -737.36% |
| 2001 | 8.36 Million CNY | 109.15% |
| 2000 | 3.99 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -904.7 Million CNY | -464.58% |
| 2024 Q2 | -7.61 Billion CNY | -741.16% |
| 2024 Q3 | -2.23 Billion CNY | 72.09% |
| 2023 FY | 248.15 Million CNY | 117.89% |
| 2023 Q3 | -1.66 Billion CNY | 6.23% |
| 2023 Q4 | 248.15 Million CNY | 114.91% |
| 2023 Q1 | -1.93 Billion CNY | -39.32% |
| 2023 Q2 | -1.77 Billion CNY | 8.15% |
| 2022 Q3 | -1.48 Billion CNY | 17.99% |
| 2022 Q4 | -1.38 Billion CNY | 6.47% |
| 2022 FY | -1.38 Billion CNY | 77.66% |
| 2022 Q1 | -6.67 Billion CNY | -7.49% |
| 2022 Q2 | -1.8 Billion CNY | 72.91% |
| 2021 Q2 | -5.02 Billion CNY | 0.35% |
| 2021 Q1 | -5.03 Billion CNY | -13.21% |
| 2021 FY | -6.21 Billion CNY | -39.58% |
| 2021 Q4 | -6.21 Billion CNY | -4.88% |
| 2021 Q3 | -5.92 Billion CNY | -17.97% |
| 2020 Q1 | -3.85 Billion CNY | -8.07% |
| 2020 FY | -4.45 Billion CNY | -24.77% |
| 2020 Q2 | -3.68 Billion CNY | 4.47% |
| 2020 Q4 | -4.45 Billion CNY | 3.92% |
| 2020 Q3 | -4.63 Billion CNY | -25.79% |
| 2019 Q1 | -2.44 Billion CNY | -11.64% |
| 2019 Q3 | -3.38 Billion CNY | -10.96% |
| 2019 Q4 | -3.56 Billion CNY | -5.3% |
| 2019 FY | -3.56 Billion CNY | -63.08% |
| 2019 Q2 | -3.05 Billion CNY | -25.03% |
| 2018 Q4 | -2.18 Billion CNY | -9.36% |
| 2018 Q3 | -1.99 Billion CNY | -10.56% |
| 2018 Q2 | -1.8 Billion CNY | 3.73% |
| 2018 Q1 | -1.87 Billion CNY | -13.86% |
| 2018 FY | -2.18 Billion CNY | -32.53% |
| 2017 Q4 | -1.65 Billion CNY | -5.99% |
| 2017 Q2 | -1.25 Billion CNY | 3.88% |
| 2017 Q1 | -1.3 Billion CNY | -23.75% |
| 2017 FY | -1.65 Billion CNY | -56.36% |
| 2017 Q3 | -1.55 Billion CNY | -24.02% |
| 2016 Q4 | -1.05 Billion CNY | -0.43% |
| 2016 Q3 | -1.05 Billion CNY | -16.17% |
| 2016 FY | -1.05 Billion CNY | 5.44% |
| 2016 Q2 | -904.58 Million CNY | 17.61% |
| 2016 Q1 | -1.09 Billion CNY | 1.64% |
| 2015 Q1 | -987.46 Million CNY | -3.62% |
| 2015 FY | -1.11 Billion CNY | -17.12% |
| 2015 Q2 | -885.88 Million CNY | 10.29% |
| 2015 Q4 | -1.11 Billion CNY | -14.85% |
| 2015 Q3 | -971.8 Million CNY | -9.7% |
| 2014 Q2 | -701.26 Million CNY | 18.78% |
| 2014 FY | -952.96 Million CNY | -14.54% |
| 2014 Q1 | -863.39 Million CNY | -3.77% |
| 2014 Q4 | -952.96 Million CNY | -21.85% |
| 2014 Q3 | -782.11 Million CNY | -11.53% |
| 2013 Q1 | -46.69 Million CNY | 8.5% |
| 2013 Q2 | 60.65 Million CNY | 229.91% |
| 2013 Q3 | -802.7 Million CNY | -1423.37% |
| 2013 FY | -832.01 Million CNY | -1530.47% |
| 2013 Q4 | -832.01 Million CNY | -3.65% |
| 2012 FY | -51.02 Million CNY | 75.4% |
| 2012 Q3 | -92.1 Million CNY | 51.78% |
| 2012 Q2 | -191.03 Million CNY | 26.38% |
| 2012 Q1 | -259.47 Million CNY | -25.1% |
| 2012 Q4 | -51.02 Million CNY | 44.6% |
| 2011 FY | -207.4 Million CNY | -88.03% |
| 2011 Q4 | -207.4 Million CNY | -59.06% |
| 2011 Q1 | -107.84 Million CNY | 2.23% |
| 2011 Q2 | -57.49 Million CNY | 46.69% |
| 2011 Q3 | -130.39 Million CNY | -126.79% |
| 2010 Q3 | -40.51 Million CNY | -186.41% |
| 2010 FY | -110.3 Million CNY | -1302.51% |
| 2010 Q4 | -110.3 Million CNY | -172.26% |
| 2010 Q1 | -28.31 Million CNY | -260.04% |
| 2010 Q2 | 46.88 Million CNY | 265.58% |
| 2009 FY | -7.86 Million CNY | -212.79% |
| 2009 Q1 | 14.27 Million CNY | 104.74% |
| 2009 Q2 | 85.1 Million CNY | 496.19% |
| 2009 Q3 | 29.44 Million CNY | -65.4% |
| 2009 Q4 | -7.86 Million CNY | -126.71% |
| 2008 FY | 6.97 Million CNY | 104.73% |
| 2008 Q1 | -70.59 Million CNY | 52.08% |
| 2008 Q2 | -88.42 Million CNY | -25.25% |
| 2008 Q4 | 6.97 Million CNY | -76.25% |
| 2008 Q3 | 29.35 Million CNY | 133.2% |
| 2007 Q4 | -147.31 Million CNY | -17.75% |
| 2007 Q3 | -125.1 Million CNY | -5.61% |
| 2007 Q2 | -118.45 Million CNY | 29.65% |
| 2007 Q1 | -168.38 Million CNY | 33.04% |
| 2007 FY | -147.31 Million CNY | 41.42% |
| 2006 Q2 | -181.9 Million CNY | 20.03% |
| 2006 Q3 | -201.24 Million CNY | -10.63% |
| 2006 Q4 | -251.45 Million CNY | -24.95% |
| 2006 FY | -251.45 Million CNY | 5.0% |
| 2006 Q1 | -227.45 Million CNY | 14.07% |
| 2005 Q3 | -242.33 Million CNY | -26.76% |
| 2005 Q2 | -191.17 Million CNY | -10.04% |
| 2005 Q1 | -173.73 Million CNY | 27.84% |
| 2005 FY | -264.7 Million CNY | -9.95% |
| 2005 Q4 | -264.7 Million CNY | -9.23% |
| 2004 Q3 | -216.76 Million CNY | -108.93% |
| 2004 Q1 | -183.1 Million CNY | 6.93% |
| 2004 Q2 | -103.74 Million CNY | 43.34% |
| 2004 FY | -240.75 Million CNY | -22.37% |
| 2004 Q4 | -240.75 Million CNY | -11.07% |
| 2003 Q3 | -133.1 Million CNY | 59.78% |
| 2003 Q2 | -330.91 Million CNY | 0.0% |
| 2003 FY | -196.74 Million CNY | -269.05% |
| 2003 Q4 | -196.74 Million CNY | -47.8% |
| 2002 Q4 | -53.31 Million CNY | 0.0% |
| 2002 FY | -53.31 Million CNY | -737.36% |
| 2001 FY | 8.36 Million CNY | 109.15% |
| 2000 FY | 3.99 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | -20.67 Billion CNY | 101.2% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | -1.53 Billion CNY | 116.178% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | -309.42 Million CNY | 180.197% |
| Aurora Optoelectronics Co.,Ltd. | -251.17 Million CNY | 198.798% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 16.8 Million CNY | -1376.752% |
| NanJing Pharmaceutical Company Limited | 9.24 Billion CNY | 97.316% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 32.59 Million CNY | -661.284% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | -954.2 Million CNY | 126.006% |